ArticleMolecules (Basel, Switzerland)2025
Therapeutic Effects of PSL-Loaded PLGA-PEG-PLGA NPs in Allergic Contact Dermatitis Model Mice.
Ryo Fujisawa, Ryuse Sakurai, Takeshi Oshizaka, Kenji Mori, Akiyoshi Saitoh, Issei Takeuchi, Kenji Sugibayashi
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Ryo FujisawaDepartment of Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Josai International University, 1 Gumyo Togane, Chiba 283-0002, Japan.
Ryuse SakuraiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278-8510, Japan.
Takeshi OshizakaDepartment of Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Josai International University, 1 Gumyo Togane, Chiba 283-0002, Japan.ORCID 0009-0009-7324-8908 Kenji MoriDepartment of Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Josai International University, 1 Gumyo Togane, Chiba 283-0002, Japan.
Akiyoshi SaitohFaculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278-8510, Japan.ORCID 0000-0001-8617-2441 Issei TakeuchiDepartment of Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Josai International University, 1 Gumyo Togane, Chiba 283-0002, Japan.ORCID 0000-0002-0611-7387 Kenji SugibayashiDepartment of Medical Pharmacy, Graduate School of Pharmaceutical Sciences, Josai International University, 1 Gumyo Togane, Chiba 283-0002, Japan.
Funding
JSPS KAKENHI JP22K06553
6 · The paper itselfAbstract
This study focused on the poly(DL-lactide-
Indexed as
Dermatitis, Allergic ContactDrug CarriersNanoparticlesPolyethylene GlycolsPrednisoloneAnimalsDisease Models, AnimalMiceParticle SizePolyglactin 910Drug CarriersPolyethylene GlycolsPolyglactin 910poly(lactic-co-glycolic acid)-polyethylene glycol-poly(lactic-co-glycolic acid)Prednisoloneallergic contact dermatitisnanoparticlepoly(DL-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly(DL-lactide-co-glycolide) (PLGA-PEG-PLGA)prednisolone
Identifiers
PMID40807467
PMCPMC12348954
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390